These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9167026)
1. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Freeman H; Roeck B; Devine D; Carter C Can J Gastroenterol; 1997 Apr; 11(3):203-7. PubMed ID: 9167026 [TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Kim BG; Kim YS; Kim JS; Jung HC; Song IS Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191 [TBL] [Abstract][Full Text] [Related]
4. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
16. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980 [TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies. Gigase P; De Clerck LS; Van Cotthem KA; Bridts CH; Stevens WJ; Van Outryve M; Pelckmans PA Dig Dis Sci; 1997 Oct; 42(10):2171-4. PubMed ID: 9365154 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. Romas E; Paspaliaris B; d'Apice AJ; Elliott PR Aust N Z J Med; 1992 Dec; 22(6):652-9. PubMed ID: 1489288 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844 [TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]